Evaluation and Validation of New Biomarkers by Mass Spectrometry (DG7)

U

Université de Sherbrooke

Status

Completed

Conditions

Diabetes Mellitus

Study type

Observational

Funder types

Other

Identifiers

NCT01025973
09-110

Details and patient eligibility

About

The investigators will perform biochemical and metabolic evaluations on cord blood, venous blood of the mother and urine of the foetus and mother using time-of-flight and tandem mass spectrometry. The investigators could evaluate, dose and validate gestational diabetes mellitus biomarkers of the fetus and mother.

Enrollment

99 patients

Sex

All

Ages

1+ day old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

For women:

  • Aged 18 or more
  • 24 weeks of gestation or more
  • Type 1, type 2 or gestational diabetes mellitus for group 1
  • Without diabetes for group 2.

For newborn:

  • 37 weeks of gestation or more
  • Birth weight 2500 g or more

Exclusion criteria

Multiple birth

Trial design

99 participants in 2 patient groups

Diabetes Mellitus
Description:
Patients with type 1, type 2 or gestational diabetes mellitus
Normal pregnancy
Description:
Patient without diabetes mellitus

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems